Bilateral Central Retinal Artery Occlusion Associated with Moyamoya Syndrome in a Sickle Cell Disease Patient

REFERENCES

• Mansi I A, Alkhunaizi A M, Al-Khatti A A. Bilateral central retinal artery occlusion secondary to sickle cell disease. Am J Hematol 2000; 64: 79–80
   Google Scholar
• Clarke W N, Vomiero G, Leonard B C. Bilateral simultaneous retinal arteriolar obstruction in a child with hemoglobin SS sickle cell disease. JAAPOS 2001; 5: 126–128
   Google Scholar
• Hasan S, Elbedawi M, Castro O, et al. Central retinal vein occlusion in sickle cell disease. South Med J 2004; 97: 202–204
   Google Scholar
• Sanghvi C, Laude A, Smith A, Dodd C L. Superior macular sparing in central retinal artery occlusion due to sickle cell anemia. Eye 2004; 18: 442–443
   Google Scholar
• Motulsky A G. Frequency of sickling disorders in US blacks. N Engl J Med 1973; 288: 31–33
   PubMed Web of Science ®Google Scholar
• Welch R, Goldberg M F. Sickle-cell hemoglobin and its relation to fundus abnormality. Arch Ophthalmol 1966; 75: 353–362
   PubMedGoogle Scholar
• Condon P I, Serjeant G R. Behaviour of untreated proliferative sickle retinopathy. Br J Ophthalmol 1980; 64: 404–411
   PubMed Web of Science ®Google Scholar
• Clarkson J G. The ocular manifestations of sickle-cell disease: a prevalence and natural history study. Tr Am Ophth Soc 1992; 90: 481–504
   PubMedGoogle Scholar
• Goldberg M F. Natural history of untreated proliferative sickle retinopathy. Arch Ophthalmol 1971; 85: 428–437
   PubMedGoogle Scholar
• Jampol L M, Condon P, Dizon-Moore R, et al. Salmon-patch hemorrhages after central retinal artery occlusion in sickle cell disease. Arch Ophthalmol 1981; 99: 237–240
   Google Scholar
• Romayananda N, Goldberg M F, Green W R. Histopathology of sickle cell retinopathy. Trans Am Acad Ophthalmol Otolaryngol 1973; 77: OP652–OP676
   Google Scholar
• Fine L C, Petrovic V, Irvine A R, Bhisitkul R B. Spontaneous central retinal artery occlusion in hemoglobin SC disease. Am J Ophthalmol 2000; 130: 680–681
   Google Scholar
• Appen R E, Wray S H, Cogan D G. Central retinal artery occlusion. Am J Ophthalmol 1975; 79: 374–381
   PubMedGoogle Scholar
• Roth S E, Magargal L E, Kimmel A S, et al. Central retinal-artery occlusion in proliferative sickle-cell retinopathy after retrobulbar injection. Ann Ophthalmol 1988; 20: 221–224
   Google Scholar
• Brown G C, Magargal L E, Shields J A, et al. Retinal arterial obstruction in children and young adults. Ophthalmology 1981; 88: 18–25
   PubMed Web of Science ®Google Scholar
• Sorr E M, Goldberg R E. Traumatic central retinal artery occlusion with sickle cell trait. Am J Ophthalmol 1975; 80: 648–652
   Google Scholar
• Radius R L, Finkelstein D. Central retinal artery occlusion (reversible) in sickle trait with glaucoma. Br J Ophthalmol 1976; 60: 428–430
   Google Scholar
• Kabakow B, Van Weimokly S S, Lyons H A. Bilateral central retinal artery occlusion. Arch Ophthalmol 1955; 54: 670–676
   Google Scholar
• Stein M R, Gay A J. Acute chorioretinal infarction in sickle trait. Arch Ophthalmol 1970; 84: 485–490
   Google Scholar
• Conrad W C, Penner R. Sickle-cell trait and central retinal-artery occlusion. Am J Ophthalmol 1967; 63: 465–468
   Google Scholar
• Suzuki J, Takaku A. Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969; 20: 288–299
   PubMed Web of Science ®Google Scholar
• Garza-Mercado R. Pseudomoyamoya in sickle cell anemia. Surg Neurol 1982; 18: 425–431
   Google Scholar
• Seeler R A, Royal J E, Powe L, Goldbarg H R. Moyamoya in children with sickle cell anemia and cerebrovascular occlusion. J Pediatr 1978; 93: 808–810
   Google Scholar
• El Ramahi K M, Al Rayes H M. Systemic lupus erythematosus associated with moyamoya syndrome. Lupus 2000; 9: 632–636
   PubMed Web of Science ®Google Scholar
• Rosser T L, Vezina G, Packer R J. Cerebrovascular abnormalities in a population of children with neurofibromatosis type I. Neurology 2005; 64: 553–555
   PubMed Web of Science ®Google Scholar
• Imaizumi M, Nukada T, Yoneda S, et al. Tuberous sclerosis with moyamoya disease. Case report. Med J Osaka Univ 1978; 28: 345–353
   PubMedGoogle Scholar
• Horn P, Pfister S, Bueltmann E, et al. Moyamoya-like vasculopathy (moyamoya syndrome) in children. Childs Nerv Sys 2004; 20: 382–391
   PubMed Web of Science ®Google Scholar
• Pavlakis S G, Verlander P C, Gould R J, et al. Fanconi anemia and moyamoya: Evidence for an association. Neurology 1995; 45: 998–1000
   PubMed Web of Science ®Google Scholar
• Lutterman J, Scott M, Nass R, Geva T. Moyamoya syndrome associated with congenital heart disease. Pediatrics 1998; 101: 57–60
   PubMedGoogle Scholar
• Desai S S, Paulino A C, Mai W Y, et al. Radiation-induced moyamoya syndrome. Int J Radiation Oncology Biol Phys 2006; 65: 1222–1277
   PubMed Web of Science ®Google Scholar
• Czartoski T, Hallam D, Lacy J M, et al. Postinfectious vasculopathy with evolution to moyamoya syndrome. J Neurol Neurosurg Psychiatry 2005; 76: 256–259
   Google Scholar
• Numaguchi Y, Gonzalez C F, Davis P C, et al. Moyamoya disease in the United States. Clin Neurol Neurosurg 1997; 99: S26–S30
   Google Scholar
• Merkel K H, Ginsberg P L, Parker J C, Jr, Post M J. Cerebrovascular disease in sickle cell anemia: a clinical, pathological and radiological correlation. Stroke 1978; 9: 45–52
   PubMed Web of Science ®Google Scholar
• Goldberg H I, Zimmerman R A. Central Nervous System. Semin Roentgenol 1987; 22: 205–212
   Google Scholar
• Chace R, Hedges T R, III. Retinal artery occlusion due to moyamoya disease. J Clin Neuro-ophthalmol 1984; 4: 31–34
   Google Scholar
• Zimmerman R A. MRI/MRA evaluation of sickle cell disease of the brain. Pediatr Radiol 2005; 35: 249–257
   Google Scholar
• Drew J M, Scott J A, Chua G T. General case of the day. Moyamoya syndrome in a child with sickle cell disease. Radiographics 1993; 13: 483–484
   Google Scholar
• Dobson S R, Holden K R, Nietert P J, et al. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood 2002; 99: 3144–3150
   PubMed Web of Science ®Google Scholar
• Chen C S, Lee A W, Kelman S, Wityk R. Anterior ischemic optic neuropathy in moyamoya disease: a first case report. Eur J Neurol 2007; 14: 823–825
   PubMed Web of Science ®Google Scholar
• Adams R J, McKie V C, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography. N Engl J Med 1988; 339: 5–11
   Google Scholar
• Russell M O, Goldberg H I, Hodson A, et al. Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood 1984; 63: 162–169
   PubMed Web of Science ®Google Scholar
• Wilimas J, Goff J R, Anderson H R, JR, et al. Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents. J Pediatr 1980; 96: 205–208
   PubMed Web of Science ®Google Scholar
• Pegelow C H, Adams R J, McKie V, et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 1995; 126: 896–899
   PubMed Web of Science ®Google Scholar
• Taniguchi M, Taki T, Tsuzuki T, Tani N, Ohnishi Y. EC-IC bypass using the distal stump of the superficial temporal artery as an additional collateral source of blood flow in patients with moyamoya disease. Acta Neurochir (Wien) 2007; 149: 393–398
   PubMed Web of Science ®Google Scholar
• Park J H, Yang S Y, Chung Y N, et al. Modified encephaloduroarteriosynangiosis with bifrontal encephalogaleoperiosteal synangiosis for the treatment of pediatric moyamoya disease. Technical note. J Neurosurg 2007; 106: 237–242, (3 Suppl)
   Google Scholar